Evidence for 12-lipoxygenase induction in the vessel wall following balloon injury

Cardiovascular Research

Volumn 41, Issue 2, 1999, Pages 489-499

  Natarajan, Rama ^a   Pei, Hong ^a   Gu, Jia Li ^a   Sarma, Jonnalegedda M ^b   Nadler, Jerry ^a  

^a Department of Diabetes   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Balloon angioplasty; Lipid signaling; Lipoxygenase; Neointimal thickening; PCR; Rats; Restenosis

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONIC ACID; PHENIDONE; PHOSPHOLIPASE;

ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENESIS; CELL MIGRATION; CELL PROLIFERATION; ENZYME INDUCTION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RESTENOSIS; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANALYSIS OF VARIANCE; ANGIOPLASTY, BALLOON; ANIMALS; ARACHIDONATE 12-LIPOXYGENASE; CAROTID ARTERY, COMMON; ENZYME INDUCTION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LIPOXYGENASE INHIBITORS; MALE; MUSCLE, SMOOTH, VASCULAR; NEOVASCULARIZATION, PATHOLOGIC; POLYMERASE CHAIN REACTION; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECURRENCE; TUNICA INTIMA;

EID: 0033019114     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00312-5     Document Type: Article

References (52)

1. Liu M.W., Roubin G.S., King S.B. Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. Circulation. 79:1989;1374-1387.
2. Libby P, Schwarz D, Brogi E, Tanaka H, Clinton SK. A cascade model for restenosis: A special case of atherosclerosis progression. Circulation 1992;86(Suppl.):III47-III52.
3. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990's. Nature. 362:1993;801-809.
4. Leimgruber P.P., Roubin G.S., Hollman J.et al. Restenosis after successful coronary angioplasty in patients with single vessel disease. Circulation. 73:1986;710-717.
5. Califf R.M., Fortin D.F., Frid D.J.et al. Restenosis after coronary angioplasty: an overview. J Am Coll Cardiol. 17:1991;2B-13B.
6. Liscovitch M. Crosstalk among multiple signal-activated phospholipases. Trends Biochem Sci. 17:1992;393-399.
7. Millar J.B.A., Rozengurt E. Arachidonic acid release by bombesin. A novel postreceptor target for heterologous mitogenic desensitization. J Biol Chem. 265:1990;19973-19979.
8. DiMarzo V. Arachidonic acid and eicosanoids as targets and effectors in second messenger interactions. Prostaglandins Leukotrienes Essent Fatty Acids. 53:1995;239-254.
9. Smith W.L. The eicosanoids and their biochemical mechanisms of action. Biochem J. 259:1989;315-324.
10. Yamamoto S. 'Enzymatic' lipid peroxidation: Reactions of mammalian lipoxygenases. Free Radic Biol Med. 10:1991;149-159.
11. Serhan C.N. Lipoxin biosynthesis and its impact in inflammatory and vascular events. Biochim Biophys Acta. 1212:1994;1-25.
12. Yamamoto S. Mammalian lipoxygenases: molecular structures and functions. Biochim Biophys Acta. 1128:1992;117-131.
13. Sigal E. The molecular biology of mammalian arachidonic acid metabolism. Am J Physiol. 260(Lung Cell Mol Physiol):1991;L13-L28.
14. Funk C.D., Furci L., FitzGerald G.A. Molecular cloning, primary structure and expression of the human platelet/erythroleukemia cell 12-lipoxygenase. Proc Natl Acad Sci USA. 87:1990;5638-5642.
15. Izumi T., Hoshiko S., Radmark O., Samuelsson S. Cloning of the cDNA for human 12-lipoxygenase. Proc Natl Acad Sci USA. 87:1990;7477-7481.
16. Yoshimoto T., Suzuki H., Yamamoto S.et al. Cloning and sequence analysis of the cDNA for arachidonate 12-lipoxygenase of porcine leukocytes. Proc Natl Acad Sci USA. 87:1990;2142-2146.
17. Watanabe T., Medina J.F., Haeggstrom J.Z., Radmark O., Samuelsson B. Molecular cloning of a 12-lipoxygenase cDNA from rat brain. Eur J Biochem. 212:1993;605-612.
18. Natarajan R., Gu J.L., Rossi J.et al. Elevated glucose and angiotensin II increase 12-lipoxygenase activity and expression in porcine aortic smooth muscle cells. Proc Natl Acad Sci USA. 90:1993;4947-4951.
19. Gu J.L., Natarajan R., Ben-Ezra J.et al. Evidence that a leukocyte-type of 12-lipoxygenase is expressed and regulated by angiotensin II in human adrenal glomerulosa cells. Endocrinology. 134:1994;70-77.
20. Kim J.A., Gu J.L., Natarajan R.et al. A leukocyte-type of 12-lipoxygenase is expressed in human vascular and mononuclear cells: evidence for upregulation by angiotensin II. Arterioscler Thromb Vasc Biol. 15:1995;942-948.
21. Natarajan R, Stern N, Nadler J. The role of arachidonic acid metabolites on renin and vascular smooth muscle cell growth. In: Sowers JR, editor. Contemporary endocrinology: Endocrinology of the vasculature. Totowa, NJ: Humana Press, 1996:373-387.
22. Parthasarathy S., Wieland E., Steinberg D. A role for endothelial cell lipoxygenase in the oxidative modification of LDL. Proc Natl Acad Sci USA. 86:1989;1046-1050.
23. Yla-Hertualla S., Rosenfeld M.E., Parthasarathy S.et al. Colocalization of 15-LO mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc Natl Acad Sci USA. 87:1990;6959-6963.
24. Wang T., Powell W. Increased monohydroxy metabolites of arachidonic and linoleic acids in LDL and aorta from atherosclerotic rabbits. Biochim Biophys Acta. 1084:1991;129-138.
25. Kuhn H., Belkner J., Zaiss S., Fahrenklemper T., Wohlfeil S. Involvement of 15-lipoxygenase in early stages of atherogenesis. J Exp Med. 179:1994;1903-1911.
26. Folcik V.A., Nivar-Aristy R.A., Krajewski L.P., Cathcart M.A. Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques. J Clin Invest. 96:1995;504-510.
27. Benz D.J., Mol M., Ezaki M.et al. Enhanced levels of lipoperoxides in low density lipoprotein incubated with murine fibroblasts expressing high levels of human 15-lipoxygenase. J Biol Chem. 270:1995;5191-5197.
28. Gerrity R, Nadler J, Natarajan R. Oxidant stress in a new swine model of diabetes-induced accelerated atherosclerosis. Circulation 1997;96:I-175 (Abstract 967).
29. Natarajan R., Bai W., Gu J.L., Rangarajan V., Nadler J. Platelet-derived growth factor BB mediated regulation of 12-lipoxygenase in porcine aortic smooth muscle cells. J Cell Physiol. 169:1996;391-400.
30. Natarajan R., Rosdahl J., Gonzales N., Bai W. Regulation of 12-lipoxygenase by cytokines in vascular smooth muscle cells. Hypertension. 30:1997;873-879.
31. Natarajan R, Gonzales N, Lanting L, Nadler J. Role of the lipoxygenase pathway in angiotensin II-induced vascular smooth muscle cell hypertrophy. Hypertension 1994;23(suppl I):I-142-I-147.
32. Indolfi C., Esposito G., Lorenzo E.D.et al. Smooth muscle cell proliferation is proportional to the degree of balloon injury in a rat model of angioplasty. Circulation. 92:1995;1230.
33. Blackwell G.J., Flower R.J. 1-Phenyl-3-pyrazolidone: an inhibitor of lipoxygenase pathway in lung and platelets. Prostaglandins. 16:1978;417-425.
34. Simons M., Edelman E.R., DeKeyser J., Langer R., Rosenberg R.D. Antisense c-myb oligonucleotides inhibit arterial SMC cell accumulation in vivo. Nature. 359:1992;67-70.
35. von der Leyen H.E., Gibbons G.H., Morishita R.et al. Gene therapy inhibiting neonatal vascular lesion: In vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA. 92:1995;1137-1142.
36. Nabel E.G., Nabel G.J. Complex models for the study of gene function in cardiovascular biology. Annu Rev Physiol. 56:1994;741-761.
37. Larsson L.-I. Tissue preparation methods for light microscopic immunohistochemistry. Appl Immunohistochem. 1:1993;2-16.
38. Bleich D., Chen S., Gu J.L.et al. Interleukin-1β regulates the expression of a leukocyte type of 12-lipoxygenase in rat islets and RIN m5F cells. Endocrinology. 136:1995;5736-5744.
39. Cercek B., Yamashita M., Dimayuga P.et al. Nuclear factor-κB activity and arterial response to balloon injury. Atherosclerosis. 131:1997;59-66.
40. Kopp E., Ghosh S. Inhibition of NF-κB by sodium salicylate and aspirin. Science. 265:1994;956-960.
41. Schwarz L., Bourassa M.G., Lesperance J.et al. Aspirin and dipyridamol in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med. 318:1988;1714-1719.
42. Roy P., Roy S.K., Mitra A., Kulkarni A.P. Superoxide generation by lipoxygenase in the presence of NADH and NADPH. Biochim Biophys Acta. 1214:1994;171-179.
43. Laurindo F.R., da Luz P.L., Uint L.et al. Evidence for superoxide radical-dependent coronary vasospasm after angioplasty in intact dogs. Circulation. 83:1991;1705-1715.
44. Libby P., Ganz P. Restenosis revisited - new targets, new therapies. New Engl J Med. 337:1997;418-419.
45. Stern N., Golub M., Nozawa K.et al. Selective inhibition of angiotensin II-mediated vasoconstriction by lipoxygenase blockade. Am J Physiol. 257:1989;H434-H443.
46. Mariani T.J., Sandefur S., Roby J.D., Pierce R.A. Collagenase-3 induction in rat lung fibroblasts requires the combined effects of tumor necrosis-alpha and 12-lipoxygenase metabolites: a model of macrophage-driven extracellular matrix remodeling during inflammatory lung injury. Mol Cell Biol. 9:1998;1411-1424.
47. Sultana C., Shen Y., Rattan V., Kalra V.K. Lipoxygenase metabolites induced expression of adhesion molecules and transendothelial migration of monocyte-like HL-60 cells is linked to protein kinase C activation. J Cell Physiol. 167:1996;477-487.
48. Khan B.V., Parthasarathy S., Alexander R.W., Medford R.M. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule gene expression in human vascular endothelial cells. J Clin Invest. 90:1995;1138-1144.
49. Brady H.R., Serhan C.N. Lipoxins: putative braking signals in host defense, inflammation and hypersensitivity. Curr Opin Nephrol Hypertens. 5:1996;20-27.
50. Osterreider W, Miller RKM, Powell JS, et al. Role of Ang II in injury-induced neointima formation in rats. Hypertension 1991;18(Suppl II):II60-II64.
51. Jawien A., Bowen-Pope D.F., Lindner V., Schwartz S.M., Clowes A.W. PDGF promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Res. 89:1993;507-511.
52. Gu J.L., Veerapanane D., Rossi J.J.et al. Ribozyme-mediated inhibition of expression of leukocyte-type 12-lipoxygenase in porcine aortic vascular smooth muscle cells. Circ Res. 77:1995;14-20.